Saturday, July 11, 2026

Drug profile · INN

iodine (131i) omburtamab

iodine (131i) omburtamab (OMBLASTYS) is an FDA-listed pharmaceutical active ingredient.

EMA: refused Various (V10) V10XA
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — iodine (131i) omburtamab
Class
Various (V10)
Route
Patents
0
Programs
0
Data quality
0.83

Quick answer

iodine (131i) omburtamab (OMBLASTYS) is an FDA-listed pharmaceutical active ingredient.

Key facts

INN iodine (131i) omburtamab
Brand OMBLASTYS
Therapeutic class Various (V10)
ATC code V10XA

Approval history

Authority Status Date
EMA refused

Related & competitor drugs

  1. besilesomab Various (V09)
  2. deferasirox Various (V03)
  3. ferric citrate coordination complex Various (V03)
  4. folic acid Various (V04)
  5. sevelamer carbonate Various (V03)
  6. sugammadex sodium Various (V03)

Frequently asked questions

What is iodine (131i) omburtamab?

iodine (131i) omburtamab (OMBLASTYS) is an FDA-listed pharmaceutical active ingredient.

What is the brand name for iodine (131i) omburtamab?

OMBLASTYS is a marketed brand name for iodine (131i) omburtamab. Check FDA Drugs@FDA for the current US label holder and prescribing information.